Prostate cancer metabolite quantification relative to water in 1H‐MRSI in vivo at 3 Tesla
Open Access
- 16 November 2010
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 65 (4) , 914-919
Abstract
1H magnetic resonance spectroscopic imaging was performed on 16 men with suspected prostate cancer using an 8‐channel external receive coil at 3 T. Choline and citrate (Cit) signals were measured in prostate lesions and normal‐appearing peripheral zone as identified on T2‐weighted images. Metabolites were quantified relative to unsuppressed water from a separately acquired magnetic resonance spectroscopic imaging dataset using LCModel. Validation experiments were also performed in a phantom containing physiological concentrations of choline, Cit, and creatine. In vitro, fair agreement between measured and true concentrations was observed, with the greatest discrepancy being a 35% underestimation of Cit. In vivo, one dataset was rejected for failure to meet the quality criterion of linewidth <15 Hz, and in 6 of 15 subjects, insufficient normal‐appearing peripheral zone tissue was identified for study. Lesions were found to have higher choline and choline/Cit, and lower Cit, than normal‐appearing peripheral zone. The smaller skew of data obtained using water normalization in comparison with metabolite ratios suggests potential usefulness in longitudinal tumor monitoring and in studies of treatment effects. Magn Reson Med, 2010.Keywords
Funding Information
- Cancer Research UK
- Addenbrooke's Charitable Trust
- University of Cambridge
- Hutchison Whampoa Ltd
- Cambridge Experimental Cancer Medicine Centre
- NIHR Cambridge Biomedical Research Centre
This publication has 29 references indexed in Scilit:
- Prostate Cancer: Value of Multiparametric MR Imaging at 3 T for Detection—Histopathologifc CorrelationRadiology, 2010
- Receive array magnetic resonance spectroscopy: Whitened singular value decomposition (WSVD) gives optimal Bayesian solutionMagnetic Resonance in Medicine, 2010
- Prediction of Prostate Cancer Recurrence Using Magnetic Resonance Imaging and Molecular ProfilesClinical Cancer Research, 2009
- Prostate Cancer: Sextant Localization at MR Imaging and MR Spectroscopic Imaging before Prostatectomy—Results of ACRIN Prospective Multi-institutional Clinicopathologic StudyRadiology, 2009
- Combined Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy Imaging in the Diagnosis of Prostate Cancer: A Systematic Review and Meta-analysisEuropean Urology, 2009
- Advances in MR Spectroscopy of the ProstateMagnetic Resonance Imaging Clinics of North America, 2008
- The rapid and automatic combination of proton MRSI data using multi-channel coils without water suppressionMagnetic Resonance Imaging, 2007
- Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 TMagnetic Resonance in Medicine, 2005
- Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: Zonal and age‐related differencesMagnetic Resonance in Medicine, 1996
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993